Cyclophosphamide monohydrate
Common Name: |
Cyclophosphamide monohydrate |
IUPAC Name: |
N,N-bis(2-chloroethyl)-2-oxo-1,3,2?5-oxazaphosphinan-2-amine;hydrate |
Molecular Formula: |
C7H17Cl2N2O3P |
SMILES: |
C1CNP(=O)(OC1)N(CCCl)CCCl.O |
Inchi: |
1S/C7H15Cl2N2O2P.H2O/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14;/h1-7H2,(H,10,12);1H2 |
Inchi Key: |
PWOQRKCAHTVFLB-UHFFFAOYSA-N |
Cas No: |
6055-19-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
279.10 |
Mass (g/mol) |
278.035 |
Molar Refractivity |
65.65 |
Net Charge |
|
HBD |
2 |
HBA |
5 |
Rt Bonds |
5 |
Rings |
|
TPSA |
60.61 |
Hetero Atoms |
|
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
|
iLOGP |
1.90 |
XLOGP3 |
0.16 |
WLOGP |
1.44 |
MLOGP |
0.14 |
ESOL Log S |
-1.34 |
ESOL Solubility (mg/ml) |
12.7 |
ESOL Solubility (mol/l) |
0.046 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.99 |
Ali Solubility (mg/ml) |
28.6 |
Ali Solubility (mol/l) |
0.1 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.71 |
Silicos-IT Solubility (mg/ml) |
0.54 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-7.89 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.344 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
3.996 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Danger |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |